Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1969 Jul;48(7):1199–1210. doi: 10.1172/JCI106084

A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies

Richard H Aster 1, Sara E Enright 1
PMCID: PMC322341  PMID: 5798625

Abstract

The tendency of platelets and leukocytes to lyse after their interaction with antibody and complement was studied by measuring the release of 51Cr from cells labeled with this isotope. Platelets from six patients with paroxysmal nocturnal hemoglobinuria (PNH) were 15-230 times more sensitive to antibodies and 10-32 times more sensitive to complement than normal platelets or platelets from patients with other types of thrombocytopenic or hemolytic disorders. Mixed white blood cell (WBC) preparations from patients with PNH were 3-20 times more sensitive to anti-WBC antibodies and 5-10 times more sensitive to C′ than were WBC preparations from normal subjects, but PNH lymphocytes showed normal immunologic reactivity. PNH platelets, like PNH erythrocytes, lysed more readily than normal platelets in acidified serum and in media of reduced ionic strength, but these characteristics were not demonstrable with PNH WBC's under the conditions of study. In PNH, platelets appear to comprise a single population with respect to their sensitivity to immune lysis, yet their survival time as measured with 51Cr falls within normal limits. PNH granulocytes likewise appear to consist of a single, uniformly sensitive population.

It is concluded that, in PNH, platelets and granulocytes share the membrane defect characteristic of erythrocytes in this disorder. These observations support the concept that PNH arises as the result of a somatic mutation in a primitive cell capable of differentiating into erythroblast, myeloblast, and megakaryoblast lines. PNH platelets or enzymatically treated normal platelets permit the detection of some types of platelet antibodies in dilutions up to 2000-fold greater than is possible with currently available methods, a finding suggesting that the immune lysis technique will prove useful for the study of platelet immunology.

Full text

PDF
1199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTER R. H., COOPER H. E., SINGER D. L. SIMPLIFIED COMPLEMENT FIXATION TEST FOR THE DETECTION OF PLATELET ANTIBODIES IN HUMAN SERUM. J Lab Clin Med. 1964 Jan;63:161–172. [PubMed] [Google Scholar]
  2. ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. I. METHODS. J Clin Invest. 1964 May;43:843–855. doi: 10.1172/JCI104970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. II. IMMUNOLOGICAL AND CLINICAL STUDIES. J Clin Invest. 1964 May;43:856–869. doi: 10.1172/JCI104971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. AUDITORE J. V., HARTMANN R. C., FLEXNER J. M., BALCHUM O. J. The erythrocyte acetylcholinesterase enzyme in paroxysmal nocturnal hemoglobinuria. Arch Pathol. 1960 May;69:534–543. [PubMed] [Google Scholar]
  5. AUDITORE J. V., HARTMANN R. C., FLEXNER J. M. Role of pH and thrombin in the PNH hemolytic system. J Appl Physiol. 1960 Jan;15:25–30. doi: 10.1152/jappl.1960.15.1.25. [DOI] [PubMed] [Google Scholar]
  6. AUDITORE J. V., HARTMANN R. C. Paroxysmal nocturnal hemoglobinuria. II. Erythrocyte acetylcholinesterase defect. Am J Med. 1959 Sep;27:401–410. doi: 10.1016/0002-9343(59)90005-1. [DOI] [PubMed] [Google Scholar]
  7. BECK W. S., VALENTINE W. N. Biochemical studies on leucocytes. II. Phosphatase activity in chronic lymphatic leucemia, acute leucemia, and miscellaneous hematologic conditions. J Lab Clin Med. 1951 Aug;38(2):245–253. [PubMed] [Google Scholar]
  8. BEUTLER E., GOLDENBURG E. W., OHNO S., YETTRA M. CHROMOSOME-21 AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. Blood. 1964 Aug;24:160–163. [PubMed] [Google Scholar]
  9. COHEN P., GARDNER F. H., BARNETT G. O. Reclassification of the thrombocytopenias by the Cr51-labeling method for measuring platelet life span. N Engl J Med. 1961 Jun 22;264:1294–contd. doi: 10.1056/NEJM196106222642506. [DOI] [PubMed] [Google Scholar]
  10. CROSBY W. H. Paroxysmal nocturnal hemoglobinuria: relation of the clinical manifestations to underlying pathogenic mechanisms. Blood. 1953 Sep;8(9):769–812. [PubMed] [Google Scholar]
  11. DACIE J. V. Paroxysmal nocturnal haemoglobinuria. Proc R Soc Med. 1963 Jul;56:587–596. [PMC free article] [PubMed] [Google Scholar]
  12. DE LA HUERGA J., YESINICK C., POPPER H. Colorimetric method for the determination of serum cholinesterase. Am J Clin Pathol. 1952 Nov;22(11):1126–1133. doi: 10.1093/ajcp/22.11_ts.1126. [DOI] [PubMed] [Google Scholar]
  13. Dameshek W. Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and "hypoplastic" leukemia have in common? Blood. 1967 Aug;30(2):251–254. [PubMed] [Google Scholar]
  14. Davies D. A., Manstone A. J., Viza D. C., Colombani J., Dausset J. Human transplantation antigens: the HL-A (Hu-1) system and its homology with the mouse H-2 system. Transplantation. 1968 Jul;6(4):571–586. [PubMed] [Google Scholar]
  15. FLEXNER J. M., AUDITORE J. V., HARTMANN R. C. Thrombin generation and clot retraction studies in paroxysmal nocturnal hemoglobinuria. Am J Clin Pathol. 1960 Jan;33:6–13. doi: 10.1093/ajcp/33.1.6. [DOI] [PubMed] [Google Scholar]
  16. French J. E. Blood platelets: morphological studies on their properties and life cycle. Br J Haematol. 1967 Jul;13(4):595–602. doi: 10.1111/j.1365-2141.1967.tb00767.x. [DOI] [PubMed] [Google Scholar]
  17. HARTMANN R. C., JENKINS D. E., Jr PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CURRENT CONCEPTS OF CERTAIN PATHOPHYSIOLOGIC FEATURES. Blood. 1965 May;25:850–865. [PubMed] [Google Scholar]
  18. HINZ C. F., Jr, HURLEY T. H., WEISMAN R., Jr Paroxysmal nocturnal hemoglobinuria; relationship of in vitro and in vivo hemolysis to clinical severity. J Lab Clin Med. 1956 Oct;48(4):495–510. [PubMed] [Google Scholar]
  19. HOROWITZ H. I., RAPPAPORT H. I., YOUNG R. C., FUJIMOTO M. M. CHANGE IN PLATELET FACTOR 3 AS A MEANS OF DEMONSTRATING IMMUNE REACTIONS INVOLVING PLATELETS: ITS USE AS A TEST FOR QUINIDINE-INDUCED THROMBOCYTOPENIA. Transfusion. 1965 Jul-Aug;5:336–343. doi: 10.1111/j.1537-2995.1965.tb01182.x. [DOI] [PubMed] [Google Scholar]
  20. Hinz C. F., Jr The hemolytic reaction in paroxysmal nocturnal hemoglobinuria. Prog Hematol. 1966;5:60–82. [PubMed] [Google Scholar]
  21. Jenkins D. E., Jr, Hartmann R. C., Kerns A. L. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells. J Clin Invest. 1967 May;46(5):753–761. doi: 10.1172/JCI105576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. KAN S. Y., GARDNER F. H. LIFE SPAN OF RETICULOCYTES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. Blood. 1965 May;25:759–766. [PubMed] [Google Scholar]
  23. Kann H. E., Jr, Mengel C. E., Meriwether W. D., Ebbert L. Production of in vitro lytic characteristics of paroxysmal nocturnal hemoglobinuria erythrocytes in normal erythrocytes. Blood. 1968 Jul;32(1):49–58. [PubMed] [Google Scholar]
  24. Lewis S. M., Dacie J. V. Neutrophil (leucocyte) alkaline phosphatase in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1965 Sep;11(5):549–556. doi: 10.1111/j.1365-2141.1965.tb00099.x. [DOI] [PubMed] [Google Scholar]
  25. NUSSEY A. M., DAWSON D. W. Paroxysmal nocturnal hemoglobinuria; case study, including evidence of affection of the marrow in the disease. Blood. 1956 Aug;11(8):757–763. [PubMed] [Google Scholar]
  26. Penny R., Galton D. A. Studies on neutrophil function. II. Pathological aspects. Br J Haematol. 1966 Sep;12(5):633–645. doi: 10.1111/j.1365-2141.1966.tb00146.x. [DOI] [PubMed] [Google Scholar]
  27. RABINOWITZ Y. SEPARATION OF LYMPHOCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES ON GLASS COLUMNS, INCLUDING TISSUE CULTURE OBSERVATIONS. Blood. 1964 Jun;23:811–828. [PubMed] [Google Scholar]
  28. ROSS J. D., ROSENBAUM E. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PRESENTING AS APLASTIC ANEMIA IN A CHILD. CASE REPORT WITH EVIDENCE OF DEFICIENT LEUKOCYTE ACETYLCHOLINESTERASE ACTIVITY. Am J Med. 1964 Jul;37:130–139. doi: 10.1016/0002-9343(64)90217-7. [DOI] [PubMed] [Google Scholar]
  29. Rosse W. F., Dacie J. V. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest. 1966 May;45(5):736–748. doi: 10.1172/JCI105388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. SANDERSON A. R. APPLICATIONS OF ISO-IMMUNE CYTOLYSIS USING RADIOLABELLED TARGET CELLS. Nature. 1964 Oct 17;204:250–253. doi: 10.1038/204250a0. [DOI] [PubMed] [Google Scholar]
  31. SHULMAN N. R. Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex. J Exp Med. 1958 May 1;107(5):665–690. doi: 10.1084/jem.107.5.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. SHULMAN N. R. Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction, and other reactions caused by the antibody of quinidine purpura. J Exp Med. 1958 May 1;107(5):697–710. doi: 10.1084/jem.107.5.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. SHULMAN N. R. Immunoreactions involving platelets. IV. Studies on the pathogenesis of thrombocytopenia in drug purpura using test doses of quinidine in sensitized individuals; their implications in idiopathic thrombocytopenic purpura. J Exp Med. 1958 May 1;107(5):711–729. doi: 10.1084/jem.107.5.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. SHULMAN N. R., MARDER V. J., HILLER M. C., COLLIER E. M. PLATELET AND LEUKOCYTE ISOANTIGENS AND THEIR ANTIBODIES: SEROLOGIC PHYSIOLOGIC AND CLINICAL STUDIES. Prog Hematol. 1964;4:222–304. [PubMed] [Google Scholar]
  35. Shulman N. R., Aster R. H., Leitner A., Hiller M. C. IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY". J Clin Invest. 1961 Sep;40(9):1597–1620. doi: 10.1172/JCI104383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sirchia G., Dacie J. V. Immune lysis of AET-treated normal red cells (PNH-like cells). Nature. 1967 Aug 12;215(5102):747–748. doi: 10.1038/215747a0. [DOI] [PubMed] [Google Scholar]
  37. YACHNIN S., RUTHENBERG J. M. PH OPTIMA IN IMMUNE HEMOLYSIS: A COMPARISON BETWEEN GUINEA PIG AND HUMAN COMPLEMENT. J Clin Invest. 1965 Jan;44:149–158. doi: 10.1172/JCI105121. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES